Related Experiment Video
Updated: Apr 27, 2026
04:42
Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
1.7K
Starting lithium prophylaxis early v. late in bipolar disorder
Lars Vedel Kessing1, Eleni Vradi1, Per Kragh Andersen1
1Lars Vedel Kessing, MD, DMSc, Psychiatric Center Copenhagen, Department O, and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark; Eleni Vradi, MSc, Per Kragh Andersen, MSc, PhD, DMSc, Department of Biostatistics, University of Copenhagen, Denmark.
Summary
Starting lithium treatment early for bipolar disorder significantly increases the likelihood of a positive response. This early intervention, whether after first contact or a single manic episode, improves treatment outcomes.
Area of Science:
- Psychiatry
- Pharmacology
- Bipolar Disorder Research
Background:
- The optimal timing for initiating lithium treatment in bipolar disorder remains uninvestigated.
- Early intervention strategies are crucial for managing chronic mental health conditions.
Purpose of the Study:
- To compare lithium response rates in bipolar disorder patients initiating treatment early versus late.
- To evaluate the impact of intervention timing on lithium efficacy.
Main Methods:
- Utilized Danish nationwide registers (1995-2012) to identify 4714 bipolar disorder patients prescribed lithium.
- Defined lithium responders as those maintaining monotherapy without hospitalization post-stabilization.
- Assessed early vs. late intervention based on timing after first psychiatric contact or a single manic/mixed episode.
Main Results:
- Early lithium initiation was associated with significantly lower non-response rates.
- Patients starting lithium earlier showed improved response regardless of the definition used (P<0.0001).
- Hazard ratios indicated a substantial benefit for early intervention (HR=0.87 for first contact, HR=0.75 for single episode).
Conclusions:
- Initiating lithium treatment early in bipolar disorder enhances the probability of treatment response.
- Timely intervention following initial psychiatric contact or a manic episode is key for better lithium outcomes.
Related Concept Videos
01:24Mania and Antimanic Drugs: Overview
791
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
791
01:26Psychosis: Goals of Pharmacotherapy
699
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
699
01:30Bipolar Disorder
1.4K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
01:30Electroconvulsive Therapy
2.5K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.5K
01:28Psychosis and Antipsychotic Drugs: Overview
1.2K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.2K
01:28Drug Therapy
443
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
443